Read this company snapshot
Daily valuation snapshot
Arcadia Biosciences, Inc.: source evidence dated 2026-10-09.
- Daily close (USD)
- $0.26
- Market capitalization (USD)
- $636,754.47
- Price / earnings (TTM)
- Not reported
- Price / book
- 1.01
The source values and product destination above identify the example to inspect.
What business is this, and what does its dated valuation mean?
Check the market day first. P/E uses trailing earnings; book value and market capitalization answer different questions.
Daily valuation dataset and column definitionsOpen the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.
Research RKDA in the app
Open the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.
Research RKDA in the appKeep reporting dates and units beside the answer, and inspect its original citations.
Company overview
Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas.
Daily valuation snapshot
See the complete daily valuation snapshot
These values come from the daily market snapshot dated 2026-10-09. TTM means trailing twelve months. Use the market date when comparing RKDA with another company.
| Daily close (USD) | $0.26 |
| Market capitalization (USD) | $636,754.47 |
| Price / earnings (TTM) | Not reported |
| Price / book | 1.01 |
No matching rows. Clear the filter to see all records.
Read RKDA's valuation metrics
Company size
Arcadia Biosciences, Inc.'s recorded market capitalization is $636,754.47. It measures the market value of the company's equity, rather than its revenue or cash balance.
Price relative to earnings
P/E compares share price with trailing annual earnings per share. For a company with losses, inspect the earnings figures directly rather than treating a negative multiple as a cheap valuation.
Price relative to book equity
RKDA's recorded price-to-book ratio is 1.01. That compares its market equity value with recorded book equity. Examine its business and balance sheet to understand why those values differ.
Research Arcadia Biosciences, Inc. with Aurora
Use the snapshot above to ask a specific question about RKDA. Ask for the report period and the figures behind the explanation, then compare the answer with the company's business description.
Continue the research
Follow RKDA's ownership disclosures to see who filed a transaction or position and when it became public. To turn a research idea into a strategy, define an entry rule and test its dated observations.